Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Prager

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Wiener Klinische Wochenschrift|April 8, 2016
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2]Martin Clodi, Heidemarie Abrahamian, Heinz Drexel, et al.
Wiener Medizinische Wochenschrift (1946)|August 28, 2013
Are there differences in LDL-C target value attainment in Austrian federal states? Yes!Max Pichler, Dominik Lautsch, Claudia Adler, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)]Martin Clodi, Heidemarie Abrahamian, Helmut Brath, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Insulin therapy of type 2 diabetes mellitus (Update 2019)]Monika Lechleitner, Martin Clodi, Heidemarie Abrahamian, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)]Martin Clodi, Heidemarie Abrahamian, Helmut Brath, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Antihyperglycemic treatment of type 2 diabetes mellitus (Update 2026)]Martin Clodi, Heidemarie Abrahamian, Felix Aberer, et al.
The New England Journal of Medicine|March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events, John J McMurray, Rury R Holman, et al.
The New England Journal of Medicine|March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events, Rury R Holman, Steven M Haffner, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Wiener Klinische Wochenschrift|April 8, 2016
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2]Martin Clodi, Heidemarie Abrahamian, Heinz Drexel, et al.
Wiener Medizinische Wochenschrift (1946)|August 28, 2013
Are there differences in LDL-C target value attainment in Austrian federal states? Yes!Max Pichler, Dominik Lautsch, Claudia Adler, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)]Martin Clodi, Heidemarie Abrahamian, Helmut Brath, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Insulin therapy of type 2 diabetes mellitus (Update 2019)]Monika Lechleitner, Martin Clodi, Heidemarie Abrahamian, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)]Martin Clodi, Heidemarie Abrahamian, Helmut Brath, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Antihyperglycemic treatment of type 2 diabetes mellitus (Update 2026)]Martin Clodi, Heidemarie Abrahamian, Felix Aberer, et al.
The New England Journal of Medicine|March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events, John J McMurray, Rury R Holman, et al.
The New England Journal of Medicine|March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events, Rury R Holman, Steven M Haffner, et al.
Pageof 7